SYF
85
2
VLO
40
-2
FRT
39
-2
CAH
47
3
ALLE
37
5
CAG
30
4
PRU
57
-3
INTU
51
2
GIS
26
3
FOXA
55
9
DHR
35
3
MA
55
-7
EIX
77
2
DVA
72
2
IFF
53
2
PBI
60
-5
WDC
41
-2
NI
75
2
MKC
56
8
LH
42
2
SYF
85
2
VLO
40
-2
FRT
39
-2
CAH
47
3
ALLE
37
5
CAG
30
4
PRU
57
-3
INTU
51
2
GIS
26
3
FOXA
55
9
DHR
35
3
MA
55
-7
EIX
77
2
DVA
72
2
IFF
53
2
PBI
60
-5
WDC
41
-2
NI
75
2
MKC
56
8
LH
42
2
Financhill
Back

Blueprint Medicines Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
37

BPMC
Blueprint Medicines

Last Price:
94.81
Seasonality Move:
-0.18%
Sell
31

SRPT
Sarepta Therapeutics

Last Price:
110.88
Seasonality Move:
16.38%
Sell
37
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $94.81. The Score for BPMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $110.86. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $94.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $110.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.39 Buy
Relative Strength Index (14 RSI): 54.43 Buy
Chaikin Money Flow: 456578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (85.11 - 97.25) Buy
Bollinger Bands (100): (85.77 - 106.49) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.05 Sell
Relative Strength Index (14 RSI): 37.69 Sell
Chaikin Money Flow: 693876 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.82 - 130.18) Sell
Bollinger Bands (100): (120.21 - 144.19) Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 94.66 Buy
20-day SMA: 92.39 Buy
50-day SMA: 90.02 Buy
200-day SMA: 95.85 Sell
8-day EMA: 94.12 Buy
20-day EMA: 93.09 Buy
50-day EMA: 92.24 Buy
200-day EMA: 91.11 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 110.05 Buy
20-day SMA: 119.95 Sell
50-day SMA: 122.58 Sell
200-day SMA: 130.17 Sell
8-day EMA: 110.83 Buy
20-day EMA: 116.6 Sell
50-day EMA: 122.63 Sell
200-day EMA: 126.32 Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.64 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):